[Levosimendan for treatment of heart failure].
Yasumura
Yoshio
Y
Division of Cardiology, National Hospital Organization Osaka National Hospital.
D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000378:metabolism*; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000378:metabolism; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology / Q000627:therapeutic use*; D018836:Inflammation Mediators / Q000378:metabolism; D020097:Natriuretic Peptide, Brain / Q000378:metabolism; D011724:Pyridazines / Q000494:pharmacology / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000188:drug therapy; D000077464:Simendan
D002316:Cardiotonic Agents; D016207:Cytokines; D006835:Hydrazones; D018836:Inflammation Mediators; D011724:Pyridazines; D020097:Natriuretic Peptide, Brain; D000077464:Simendan; D002118:Calcium